Related Experiment Video
Updated: Jun 27, 2026
07:54
Implantation and Monitoring by PET/CT of an Orthotopic Model of Human Pleural Mesothelioma in Athymic Mice
Published on: December 21, 2019
Problems in mesothelioma diagnosis.
1Department of Cellular Pathology, Southampton University Hospitals NHS Trust, Southampton, UK. bruce.addis@suht.swest.nhs.uk
Histopathology
|December 5, 2008
Summary
Diagnosing malignant mesothelioma is challenging for pathologists due to its similarity to benign conditions and other tumors. Immunohistochemistry aids diagnosis but requires careful interpretation alongside clinical and radiological data.
Area of Science:
- Pathology
- Oncology
Background:
- Increasing incidence of malignant mesothelioma presents diagnostic challenges.
- Distinguishing mesothelioma from benign changes and other tumors is difficult.
Purpose of the Study:
- To review diagnostic challenges in malignant mesothelioma.
- To discuss the utility and limitations of immunohistochemistry in mesothelioma diagnosis.
Main Methods:
- Literature review focusing on immunohistochemistry in mesothelioma.
- Analysis of differential diagnosis for pleural-based tumors.
Main Results:
- Immunohistochemistry is crucial but requires integration with clinical and radiological findings.
- Morphological variations in mesothelioma necessitate broad diagnostic considerations.
Conclusions:
- Accurate mesothelioma diagnosis relies on a multifaceted approach.
- Understanding immunohistochemistry's role and limitations is key for challenging cases.
